Edition:
United States

GNC Holdings Inc (GNC.N)

GNC.N on New York Stock Exchange

4.42USD
23 Feb 2018
Change (% chg)

$0.37 (+9.14%)
Prev Close
$4.05
Open
$4.20
Day's High
$4.52
Day's Low
$4.06
Volume
2,342,456
Avg. Vol
921,238
52-wk High
$10.95
52-wk Low
$3.13

Select another date:

Wed, Feb 21 2018

GNC tweaks maturity extension amendment to thwart holdouts

NEW YORK, Feb 21 (LPC) - Ailing US vitamin and supplement retailer GNC Holdings Inc has sweetened the terms of a complex amendment to its existing credit agreement to extend a looming March 2019 debt maturity, after early consents from lenders fell short of a required threshold, according to three sources familiar with the transaction.

BRIEF-Harbin Pharma Scraps Plan For Unit To Bid For GNC's China Business

* SAYS CONTROLLING SHAREHOLDER SIGNS AGREEMENT TO BUY GNC HOLDINGS' CONVERTIBLE PREFERENCE SHARES WORTH $299.95 MILLION

China's Harbin Pharma to buy stake in U.S. health retailer GNC

HONG KONG China's state-controlled drugmaker Harbin Pharmaceutical Group Holding Co will buy an about 40 percent stake in U.S. nutritional supplements retailer GNC Holdings Inc for $300 million and are in talks for a joint venture in China, the companies said.

China's Harbin Pharma to buy stake in U.S. health retailer GNC

HONG KONG, Feb 14 China's state-controlled drugmaker Harbin Pharmaceutical Group Holding Co will buy an about 40 percent stake in U.S. nutritional supplements retailer GNC Holdings Inc for $300 million and are in talks for a joint venture in China, the companies said.

BRIEF-GNC Holdings Says Launched Certain Amendments To Credit Agreement

* GNC HOLDINGS SAYS LAUNCHED CERTAIN AMENDMENTS TO CREDIT AGREEMENT DATED AS OF NOV 26, 2013​ - SEC FILING

BRIEF-GNC Holdings Says On Deal Termination Co to Pay Termination Fee Of Either $10 Mln Or $18 Mln To Harbin Pharmaceutical

* GNC HOLDINGS - ON DEAL TERMINATION UNDER CIRCUMSTANCES, CO WILL PAY FEE OF EITHER $10 MILLION OR $18 MILLION TO HARBIN PHARMACEUTICAL GROUP - SEC FILING Source text: (http://bit.ly/2o4g6KY) Further company coverage:

BRIEF-GNC And Harbin Pharmaceutical Announce $300 Mln Strategic Investment

* GNC AND HARBIN PHARMACEUTICAL ANNOUNCE $300 MILLION STRATEGIC INVESTMENT AND CHINA JOINT VENTURE

BRIEF-GNC Holdings Q4 Loss Per Share $2.99

* GNC HOLDINGS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS

BRIEF-GNC Holdings Sees Q4 Adj Diluted Earnings Per Share To Be $0.24 To $0.25

* SEES AN INCREASE IN Q4 SAME STORE SALES FOR DOMESTIC COMPANY-OWNED STORES (INCLUDING GNC.COM SALES) OF 5.7%

Fitch Downgrades GNC's IDR to 'RD' / Upgrades IDR to 'CCC' on Completion of Debt Exchange

(The following statement was released by the rating agency) NEW YORK, December 29 (Fitch) Fitch Ratings has downgraded GNC Holdings, Inc.'s Long-Term Issuer Default Rating (IDR) to 'RD' from 'C' following the Dec. 27 closing of its distressed debt exchange (DDE) for approximately $99 million of its $288 million in convertible notes for approximately 14.6 million shares (or approximately 17%) of its common equity, valued at around $50 million. Subsequently, Fitch upgraded GNC's Long-Term IDR to '

Select another date: